Mediterranean Journal of Pharmacy and Pharmaceutical Sciences (Mediterr J Pharm Pharm Sci., ISSN: 2789-1895e, 2958-3101p) publishes papers on a broad range of drug research and pharmacy practice for those working on the drugs and clinical areas. It is a peer-reviewed and open-access journal that allows readers and authors to read and download published papers free of charge. All submissions are considered on condition that their contents have not appeared elsewhere. The Journal conforms to standard Publication Ethics. The language of the journal is English.
All the contents of this journal are licensed under a Creative Commons Attribution 4.0 International License.
Manuscripts should be addressed to the Editor-in-Chief,
Prof. Fathi M. Sherif: editor@medjpps.com / f.sherif@uot.edu.ly
JOURNAL STATES: Acceptance rate: 25.3%, Submission to acceptance: 8-12 weeks
Google Scholar
Volume 6, Issue 3, 2026 September
6(3), 2026 September
Review
Highlight https://doi.org/10.5281/zenodo.21717089
Mediterr J Pharm Pharm Sci, vol.6 n3, 1-15, September, 2026, Publication date July 06, 2026 Natural biodegradable materials for advanced pharmaceutical drug delivery systems: A comprehensive review Biocompatibility, bioavailability, nanoencapsulation, polymer-based carriers, tissue engineering ReviewPharmaceutics
Mediterr J Pharm Pharm Sci, vol.6 n3, 1-15, September, 2026, Publication date July 06, 2026 Natural biodegradable materials for advanced pharmaceutical drug delivery systems: A comprehensive review Biocompatibility, bioavailability, nanoencapsulation, polymer-based carriers, tissue engineering ReviewPharmaceutics
Original article
Highlight https://doi.org/10.5281/zenodo.21718939
Mediterr J Pharm Pharm Sci, vol.6 n3, 16-21, September, 2026, Publication date July 27, 2026 Estradiol hormone and oxidative stress markers in women with polycystic ovary syndrome Estradiol, glutathione, malondialdehyde, peroxynitrite, polycystic ovary syndrome, oxidative stress Original articlePharmacology
Mediterr J Pharm Pharm Sci, vol.6 n3, 16-21, September, 2026, Publication date July 27, 2026 Estradiol hormone and oxidative stress markers in women with polycystic ovary syndrome Estradiol, glutathione, malondialdehyde, peroxynitrite, polycystic ovary syndrome, oxidative stress Original articlePharmacology
Highlight https://doi.org/10.5281/zenodo.21719557
Mediterr J Pharm Pharm Sci, vol.6 n3, 22-32, September, 2026, Publication date July 28, 2026 Knowledge, handling practices, and systemic challenges regarding safe chemotherapy management among Libyan healthcare providers in Benghazi Chemotherapy safety, hazardous drugs, healthcare providers, pharmacist, occupational exposure Original articlePharmacy practice
Mediterr J Pharm Pharm Sci, vol.6 n3, 22-32, September, 2026, Publication date July 28, 2026 Knowledge, handling practices, and systemic challenges regarding safe chemotherapy management among Libyan healthcare providers in Benghazi Chemotherapy safety, hazardous drugs, healthcare providers, pharmacist, occupational exposure Original articlePharmacy practice
Highlight https://doi.org/10.5281/zenodo.21833611
Mediterr J Pharm Pharm Sci, vol.6 n3, 33-39, September, 2026, Publication date August 01, 2026 The impact of drug interactions on biochemical parameters in Libyan patients with diabetes and hyperlipidemia Diabetes mellitus, drug-drug interactions, drug-related problems, hyperlipidemia, polypharmacy Original articleClinical biochemistry
Mediterr J Pharm Pharm Sci, vol.6 n3, 33-39, September, 2026, Publication date August 01, 2026 The impact of drug interactions on biochemical parameters in Libyan patients with diabetes and hyperlipidemia Diabetes mellitus, drug-drug interactions, drug-related problems, hyperlipidemia, polypharmacy Original articleClinical biochemistry
Highlight https://doi.org/10.5281/zenodo.21833707
Mediterr J Pharm Pharm Sci, vol.6 n3, 40-49, September, 2026, Publication date August 02, 2026 Impact of cardiovascular risk screening in an academic institution, Benghazi, Libya Academic institution, cardiovascular disease, cardiovascular risk, Libyan International University Original articlePharmacy practice
Mediterr J Pharm Pharm Sci, vol.6 n3, 40-49, September, 2026, Publication date August 02, 2026 Impact of cardiovascular risk screening in an academic institution, Benghazi, Libya Academic institution, cardiovascular disease, cardiovascular risk, Libyan International University Original articlePharmacy practice
https://doi.org/10.5281/zenodo.21833847
Mediterr J Pharm Pharm Sci, vol.6 n3, 50-64, September, 2026, Publication date August 04, 2026 The burden of dyslipidaemia in an urban Libyan population: Epidemiological assessment and a review of modern therapy Dyslipidemia, prevalence, patterns, risk group, Zawia Original articlePharmacology
Mediterr J Pharm Pharm Sci, vol.6 n3, 50-64, September, 2026, Publication date August 04, 2026 The burden of dyslipidaemia in an urban Libyan population: Epidemiological assessment and a review of modern therapy Dyslipidemia, prevalence, patterns, risk group, Zawia Original articlePharmacology
Prof. Fathi Mohamed Sherif
Periodicity: Quarterly
Published by: Libyan Association for Pharmacists
Most Viewed
Most downloaded
